Encompass Health Corp [EHC] stock prices are up 2.63% to $95.26 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The EHC shares have gain 4.31% over the last week, with a monthly amount glided 4.13%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Encompass Health Corp [NYSE: EHC] stock has seen the most recent analyst activity on July 10, 2024, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $100. Previously, Barclays started tracking the stock with Overweight rating on March 06, 2024, and set its price target to $95. On March 14, 2023, Barclays initiated with a Equal Weight rating and assigned a price target of $57 on the stock. UBS started tracking the stock assigning a Buy rating and suggested a price target of $98 on September 24, 2021. Raymond James upgraded its rating to a Strong Buy and raised its price target to $107 on August 02, 2021. Barclays upgraded its rating to Overweight for this stock on November 23, 2020, but kept the price target unchanged to $96.
The stock price of Encompass Health Corp [EHC] has been fluctuating between $57.55 and $94.59 over the past year. Currently, Wall Street analysts expect the stock to reach $93.17 within the next 12 months. Encompass Health Corp [NYSE: EHC] shares were valued at $95.26 at the most recent close of the market. An investor can expect a potential drop of -2.19% based on the average EHC price forecast.
Analyzing the EHC fundamentals
The Encompass Health Corp [NYSE:EHC] reported sales of 5.07B for trailing twelve months, representing a surge of 9.61%. Gross Profit Margin for this corporation currently stands at 0.38% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.24 and Total Capital is 0.13. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.32.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 93.03 points at the first support level, and at 90.81 for the second support level. However, for the 1st resistance point, the stock is sitting at 96.72, and for the 2nd resistance point, it is at 98.18.
Ratios To Look Out For
It’s worth pointing out that Encompass Health Corp [NYSE:EHC]’s Current Ratio is 1.35. In addition, the Quick Ratio stands at 1.35 and the Cash Ratio stands at 0.26. Considering the valuation of this stock, the price to sales ratio is 1.89, the price to book ratio is 5.22 and price to earnings (TTM) ratio is 24.28.
Transactions by insiders
Recent insider trading involved COLTHARP DOUGLAS E, EVP & Chief Financial Officer, that happened on Aug 13 ’24 when 12260.0 shares were sold. Officer, Douglas Coltharp completed a deal on Aug 13 ’24 to buy 12260.0 shares. Meanwhile, Chief Medical Officer Charbonneau Elissa Joy sold 10000.0 shares on May 24 ’24.
